celastrol has been researched along with triptohypol C in 7 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (triptohypol C) | Trials (triptohypol C) | Recent Studies (post-2010) (triptohypol C) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 9 | 0 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, JS; Kim, YM; Lee, JY; Lee, WS; Park, KH; Park, SJ; Rho, MC; Ryu, YB; Seo, WD | 1 |
| Cascante, M; Cortés, R; Figueiredo, SAC; Salvador, JAR | 2 |
| Cowley, MA; De Angelis, M; Dodd, GT; Geerlof, A; Kyriakou, E; Lenhart, D; Messias, AC; Pfluger, PT; Pfuhlmann, K; Plettenburg, O; Sattler, M; Schmidt, S; Schramm, KW; Schriever, SC; Simonds, SE; Tiganis, T; Tschöp, MH | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Chen, Z; Hu, C; Huang, Z; Kang, Q; Li, M; Li, X; Li, Z; Lian, B; Peng, S; Su, Y; Yan, S; Yu, H; Zeng, Z; Zhang, D; Zhang, XK; Zhu, Y | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
7 other study(ies) available for celastrol and triptohypol C
| Article | Year |
|---|---|
SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii.
Topics: Antiviral Agents; Benzoquinones; Models, Molecular; Plant Extracts; Severe acute respiratory syndrome-related coronavirus; Tripterygium; Triterpenes | 2010 |
Novel celastrol derivatives with improved selectivity and enhanced antitumour activity: Design, synthesis and biological evaluation.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Conformation; Pentacyclic Triterpenes; Structure-Activity Relationship; Triterpenes | 2017 |
Design, synthesis and biological evaluation of novel C-29 carbamate celastrol derivatives as potent and selective cytotoxic compounds.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Cytotoxins; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pentacyclic Triterpenes; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured | 2017 |
Celastrol Promotes Weight Loss in Diet-Induced Obesity by Inhibiting the Protein Tyrosine Phosphatases PTP1B and TCPTP in the Hypothalamus.
Topics: Allosteric Site; Animals; Anti-Obesity Agents; Catalytic Domain; Diet, High-Fat; Hypothalamus; Magnetic Resonance Spectroscopy; Male; Mice, Transgenic; Obesity; Pentacyclic Triterpenes; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 2; Structure-Activity Relationship; Triterpenes; Weight Loss | 2018 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
SAR study of celastrol analogs targeting Nur77-mediated inflammatory pathway.
Topics: Animals; Anti-Inflammatory Agents; Binding Sites; Drug Design; Hep G2 Cells; Humans; Molecular Docking Simulation; Molecular Structure; Nuclear Receptor Subfamily 4, Group A, Member 1; Pentacyclic Triterpenes; Protein Binding; Sequestosome-1 Protein; Structure-Activity Relationship; TNF Receptor-Associated Factor 2; Triterpenes; Zebrafish | 2019 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |